As robotics and autonomy companies build Pittsburgh’s reputation as an essential tech hub, life sciences might soon be the next frontier of progress. It’s a time of growing excitement for the field in Pittsburgh. Cognition Therapeutics, a drug discovery company based in the South Side, announced plans earlier this summer for an initial public offering of $50 million, which officially launched this morning. And in June, a million dollar grant from the Richard King Mellon Foundation brought the formation of the Pittsburgh Life Sciences Alliance, which will likely see more news in the next few months.
Image: In a lab. (Photo courtesy of the University City Science Center)
